Search research articles
Contact Us
Filters
Showing results (71-80 of 112) with videos related to
Page
of 12
Sort By:
Hematological Oncology
|
September 7, 2020
Over expression of brain and acute leukemia, cytoplasmic and ETS-related gene is associated with poor outcome in acute myeloid leukemia
Syed Khizer Hasan, Nikhil V Patkar, Deepan Rajamanickam, et al.
Blood Cell Therapy
|
June 8, 2026
Outcomes of PTCY-Based Haploidentical Transplants and Donor Factors Affecting Outcomes: A 12-year Experience from India
Nishant Jindal, Anant Gokarn, Malini Garg, et al.
International Journal of Hematology
|
September 3, 2020
Bortezomib and cyclophosphamide based chemo-mobilization in multiple myeloma
Bhausaheb Bagal, Anant Gokarn, Sachin Punatar, et al.
Indian Journal of Pathology & Microbiology
|
February 15, 2017
Immunogenetics of chronic lymphocytic leukemia
Nikhil Patkar, Nikhil Rabade, Pratibha Amare Kadam, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
February 1, 2021
Clinical course of severe COVID19 treated with tocilizumab and antivirals post-allogeneic stem cell transplant with extensive chronic GVHD
Sumeet Mirgh, Anant Gokarn, Sachin Punatar, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
July 28, 2023
Novel covalent CDK7 inhibitor potently induces apoptosis in acute myeloid leukemia and synergizes with Venetoclax
Tarang Gaur, Ramulu Poddutoori, Leena Khare, et al.
Journal for Immunotherapy of Cancer
|
May 23, 2020
Flow cytometric evaluation of CD38 expression levels in the newly diagnosed T-cell acute lymphoblastic leukemia and the effect of chemotherapy on its expression in measurable residual disease, refractory disease and relapsed disease: an implication for anti-CD38 immunotherapy
Prashant Ramesh Tembhare, Harshini Sriram, Twinkle Khanka, et al.
Blood Advances
|
February 26, 2021
Outcomes and prognostic factors in adolescents and young adults with ALL treated with a modified BFM-90 protocol
Akhil Rajendra, Hasmukh Jain, V N Avinash Bonda, et al.
Cancer Medicine
|
July 16, 2025
Moving Beyond G-CSF Mobilization-Learning From a 15-Year Experience of Different Stem Cell Mobilization Regimens in Multiple Myeloma
Sumeet Mirgh, Bhausaheb Bagal, Sachin Punatar, et al.
Molecular Carcinogenesis
|
February 13, 2026
TGFβ-Mediated Overexpression of Podoplanin Serves as a Potential Diagnostic Biomarker in Acute Promyelocytic Leukemia
Akash Maity, Rohit Kumar, Madhavi Dutta, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 112) with videos related to
Sort By:
Page
of 12
Hematological Oncology
|
September 7, 2020
Over expression of brain and acute leukemia, cytoplasmic and ETS-related gene is associated with poor outcome in acute myeloid leukemia
Syed Khizer Hasan, Nikhil V Patkar, Deepan Rajamanickam, et al.
Blood Cell Therapy
|
June 8, 2026
Outcomes of PTCY-Based Haploidentical Transplants and Donor Factors Affecting Outcomes: A 12-year Experience from India
Nishant Jindal, Anant Gokarn, Malini Garg, et al.
International Journal of Hematology
|
September 3, 2020
Bortezomib and cyclophosphamide based chemo-mobilization in multiple myeloma
Bhausaheb Bagal, Anant Gokarn, Sachin Punatar, et al.
Indian Journal of Pathology & Microbiology
|
February 15, 2017
Immunogenetics of chronic lymphocytic leukemia
Nikhil Patkar, Nikhil Rabade, Pratibha Amare Kadam, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
February 1, 2021
Clinical course of severe COVID19 treated with tocilizumab and antivirals post-allogeneic stem cell transplant with extensive chronic GVHD
Sumeet Mirgh, Anant Gokarn, Sachin Punatar, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
July 28, 2023
Novel covalent CDK7 inhibitor potently induces apoptosis in acute myeloid leukemia and synergizes with Venetoclax
Tarang Gaur, Ramulu Poddutoori, Leena Khare, et al.
Journal for Immunotherapy of Cancer
|
May 23, 2020
Flow cytometric evaluation of CD38 expression levels in the newly diagnosed T-cell acute lymphoblastic leukemia and the effect of chemotherapy on its expression in measurable residual disease, refractory disease and relapsed disease: an implication for anti-CD38 immunotherapy
Prashant Ramesh Tembhare, Harshini Sriram, Twinkle Khanka, et al.
Blood Advances
|
February 26, 2021
Outcomes and prognostic factors in adolescents and young adults with ALL treated with a modified BFM-90 protocol
Akhil Rajendra, Hasmukh Jain, V N Avinash Bonda, et al.
Cancer Medicine
|
July 16, 2025
Moving Beyond G-CSF Mobilization-Learning From a 15-Year Experience of Different Stem Cell Mobilization Regimens in Multiple Myeloma
Sumeet Mirgh, Bhausaheb Bagal, Sachin Punatar, et al.
Molecular Carcinogenesis
|
February 13, 2026
TGFβ-Mediated Overexpression of Podoplanin Serves as a Potential Diagnostic Biomarker in Acute Promyelocytic Leukemia
Akash Maity, Rohit Kumar, Madhavi Dutta, et al.
Page
of 12